FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Credit Suisse reaffirms its Neutral rating

Analyst Christoph Gretler from Credit Suisse research gives the stock a Neutral rating. Previously set at EUR 42, the target price has been raised to EUR 45.

Related Keywords

Christoph Gretler ,Credit Suisse ,Analyst Christoph Gretler ,